Business Wire

Duravant to Acquire Pattyn, Provider of Packaging Automation Systems for Bulk and Industrial Applications

Share

Automation solutions leader Duravant has signed a definitive agreement to acquire Pattyn.

Duravant LLC (“Duravant”), a global engineered equipment and automation solutions provider to the food processing, packaging and material handling sectors, announced today that it has entered into a definitive agreement to acquire the Pattyn Group BV (‘Pattyn”), a designer and manufacturer of automation systems specializing in B2B packaging. Pattyn is recognized as the premier leader for delivering comprehensive automation solutions and value-added services for bag-in-box packaging applications. Headquartered in Bruges, Belgium, Pattyn has over 70 years of expertise in machinery design and turnkey systems for counting, weighing, filling, and packing technologies for food, ingredients, and various non-food sectors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250207117623/en/

“We are extremely excited to partner with Pattyn,” said Mike Kachmer, Chairman and CEO of Duravant. “Pattyn has a rich history delivering high quality solutions to a global customer base in over 80 countries. Their impressive growth is attributed to their unwavering focus on customer satisfaction and building lasting relationships, which aligns perfectly with Duravant’s dedication to ensuring customer success.”

Pattyn operates out of six specialized manufacturing sites in Belgium, France and Spain and has sales and service divisions in North America and Asia. Founded by Jean Pattyn in 1952 and expanded through the vision of Paul Pattyn in 1976, the company grew from a local business to a worldwide supplier of packaging automation. Pattyn’s third generation owners and shareholders Stan Pattyn and Lynn Pattyn, alongside Pattyn COO Benjamin de Chilly, further led the company’s transformation with continuous innovation and development of new packaging technologies, digital offerings, and a service-minded approach from design to installation and complete aftermarket support.

“Pattyn has had a strong track record of solid performance, and we know that our potential to grow faster will happen alongside a strong partner,” said Stan Pattyn. “Through further investments in product development, operational excellence, and emerging market expansion, we will not only continue to thrive, but we will be empowered to better serve our customers and partners around the globe. Duravant is the perfect partner for the Pattyn Group and our employees.”

“We are thrilled to join forces with Duravant and collaborate with their family of world-class brands,” said Lynn Pattyn. “Duravant has a leading position across a wide array of end markets, from food & beverage to consumer goods, agriculture and industrial goods, to logistics and e-commerce. Pattyn’s opportunity to expand into new end markets with Duravant is core to our growth vision. But what’s most exciting is that Duravant’s customer-centric culture aligns perfectly with Pattyn’s commitment to delivering an excellent customer experience. We share that same DNA.”

Benjamin de Chilly adds, “Duravant is a true global organization with deep roots in Europe. They have a strong manufacturing footprint on the continent with renowned automation equipment brands such as Mespack, Votech, Marelec, Foodmate, Henneken, Multiscan, FMH Conveyors and Motion06. They recently invested in emerging markets Brazil, Mexico, China and Thailand where they established local sales, parts and service infrastructure to enhance their ability to serve customers in those regions.”

Pattyn represents a strategic acquisition for Duravant, expanding the company’s packaging machinery portfolio with innovative engineered solutions. Pattyn’s advanced automation technologies provide custom solutions through modular system designs while their equipment and consumables meet the highest food safety standards. Pattyn’s strong solution set for bakery applications further deepens Duravant’s relationships with customers in this sector.

The transaction, which remains subject to customary regulatory approvals, is expected to close in the second quarter of 2025. Following the close of the transaction, Pattyn will be a distinct Operating Company within Duravant’s Packaging Solutions Group. The current Pattyn Group management team will continue to oversee operations after the completion of the sale, and Pattyn’s 550 employees will join Duravant’s 3600 employees around the globe.

About Duravant

Headquartered in Downers Grove, IL, Duravant is a global engineered equipment company with manufacturing, sales and service facilities throughout North America, South America, Europe and Asia. Through their portfolio of operating companies, Duravant delivers trusted end-to-end automation solutions for customers and partners through engineering and integration expertise, project management and operational excellence. With worldwide sales distribution and support through the Duravant Lifecycle Services network, they provide immediate and lifetime aftermarket support to all the markets they serve in the protein processing, food sorting and handling, packaging, and material handling sectors. Duravant’s market-leading brands are synonymous with innovation, durability and reliability. For more information, visit www.duravant.com.

About Pattyn

Headquartered in Bruges, Belgium, Pattyn Group is a manufacturer and service provider of innovative and highly engineered packaging automation equipment specializing in modular solutions for counting, weighing, filling and bag-in-a-box applications. Since 1952, the company serves the B2B packaging segment and a diverse customer base that includes food and non-food producers in over 80 countries worldwide. Committed to fostering lifetime partnerships, Pattyn designs and delivers turnkey packaging lines with innovative modular designs that deliver custom solutions. The company provides aftermarket support with consumables, parts and comprehensive service programs. With 6 manufacturing sites in Belgium, France and Spain, and sales and service hubs in the United States and Asia, Pattyn partners with their customers to improve the efficiency, performance and quality of their industrial packaging needs. For more information, visit www.pattyn.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250207117623/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Nexo Becomes First-Ever Title Partner of the U.S. ATP 500 Dallas Open in Multi-Year Deal13.1.2026 16:30:00 CET | Press release

The agreement builds on Nexo’s long-term approach to partnerships with established global sports institutions. Nexo, the digital assets wealth platform, has been named the U.S. ATP 500 Dallas Open’s first-ever Title Partner under a multi-year agreement beginning in 2026, as the company advances its long-term brand strategy through leading global sports properties. The partnership was unveiled in Dallas alongside the debut of the Nexo Dallas Open brand and the resurfacing of two public tennis courts in North Texas. As one of only two ATP 500 tournaments in the U.S. and the country’s sole indoor ATP Tour championship, the Dallas Open places Nexo among a limited group of ATP 500 title partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113901822/en/ The Nexo Dallas Open “This partnership with Nexo represents a transformative milestone for the Dallas Open,” said Tournament Director Peter Lebedevs. “Securing a title spons

Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik13.1.2026 15:01:00 CET | Press release

Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025. Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh. The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “R&D organ

Wasabi Raises $70M in New Equity to Power the Next Era of Data Infrastructure13.1.2026 15:00:00 CET | Press release

At a $1.8 billion valuation, backed by L2 Point and Pure Storage, the company scales AI-first cloud storage to meet the explosive demands of modern data Wasabi Technologies, the Hot Cloud Storage company, today announced a $70 million equity funding round led by L2 Point Management with participation from Pure Storage and existing investors including Fidelity Management & Research Company. The new round values Wasabi at $1.8 billion and brings the company’s total funding to over $600 million. The capital will be used to accelerate Wasabi’s expansion into AI infrastructure, broaden its global footprint, and enhance its product portfolio to meet the growing data demands of enterprises and AI developers worldwide. “We’re ushering in the next generation of cloud storage, powering data-intensive workloads like generative AI and autonomous systems,” said David Friend, co-founder and CEO of Wasabi Technologies. “This funding underscores Wasabi’s strong market position and continued growth as

HumanX Amsterdam Reveals First 100 Speakers, Bringing Global AI Powerhouses to Europe13.1.2026 14:00:00 CET | Press release

Anton Osika (Lovable), May Habib (Writer), Jan Oberhauser (n8n) & Eléonore Crespo (Pigment) headline a diverse lineup spanning AI innovation and enterprise adoption HumanX, the global AI summit for executives and innovators, today unveiled its first 100 speakers and opened registration for HumanX Amsterdam, taking place 22–24 September 2026 at The RAI. Built by the team behind Money20/20, Shoptalk, and HLTH, HumanX Amsterdam brings the proven formula of its #1 U.S. flagship event and ecosystem gathering to Europe. The event convenes over 2,500 senior leaders focused on moving beyond the hype to drive practical, responsible AI implementation across industries. Speakers Leading the Conversation The first 100 speakers include AI company founders such as Anton Osika (Lovable), Jan Oberhauser (n8n), May Habib (Writer), Arvind Jain (Glean), and Jarek Kutylowski (DeepL), alongside executives scaling AI in the enterprise, including Clay Bavor (Sierra), Des Traynor (Intercom), and Eléonore Cres

GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug13.1.2026 14:00:00 CET | Press release

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue the development of Debio1453, a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae. With 82 million new cases each year, and the continued spread of multidrug-resistant N. gonorrhoeae strains, gonorrhea represents a global health crisis. This new partnership will help ensure that gonorrhea continues to be a treatable disease and will alleviate the risk of the emergence of future resistance, by ensuring that the antibiotic pipeline continues to be replenished. Gonorrhea caused by N. gonorrhoeae is currently in danger of becoming untreatable because of antimicrobial resistance (AMR). Having developed resistance to almost all antibiotics used to treat it, only one last recommended treatment, ceftriaxone, remains effective, and now we are seeing a growing number of cases that are

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye